Tags

Type your tag names separated by a space and hit enter

Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease.
Cell Stem Cell. 2020 Jul 02; 27(1):6-7.CS

Abstract

Many type 2 diabetes patients develop cardiovascular disease (CVD) while some are protected. Toyohara et al. (2020) find that elevated arylacetamide deacetylase (AADAC) expression in vascular smooth muscle cells (dVSMCs) differentiated from patient-derived induced pluripotent stem cells is associated with cardioprotection. AADAC overexpression alters multiple dVSMC properties and decreases murine CVD.

Authors+Show Affiliations

Heart Research Institute, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. Electronic address: ashish.misra@hri.org.au.Department of Medicine/Divsion of Cardiology, and the Cardiovascular Research Center, New York University Grossman School of Medicine, New York, NY, USA. Electronic address: edward.fisher@nyulangone.org.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32619519

Citation

Misra, Ashish, and Edward A. Fisher. "Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease." Cell Stem Cell, vol. 27, no. 1, 2020, pp. 6-7.
Misra A, Fisher EA. Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease. Cell Stem Cell. 2020;27(1):6-7.
Misra, A., & Fisher, E. A. (2020). Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease. Cell Stem Cell, 27(1), 6-7. https://doi.org/10.1016/j.stem.2020.06.012
Misra A, Fisher EA. Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease. Cell Stem Cell. 2020 Jul 2;27(1):6-7. PubMed PMID: 32619519.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease. AU - Misra,Ashish, AU - Fisher,Edward A, PY - 2020/7/4/entrez PY - 2020/7/4/pubmed PY - 2020/7/4/medline SP - 6 EP - 7 JF - Cell stem cell JO - Cell Stem Cell VL - 27 IS - 1 N2 - Many type 2 diabetes patients develop cardiovascular disease (CVD) while some are protected. Toyohara et al. (2020) find that elevated arylacetamide deacetylase (AADAC) expression in vascular smooth muscle cells (dVSMCs) differentiated from patient-derived induced pluripotent stem cells is associated with cardioprotection. AADAC overexpression alters multiple dVSMC properties and decreases murine CVD. SN - 1875-9777 UR - https://www.unboundmedicine.com/medline/citation/32619519/Translational_Research_in_Culture:_AADAC,_Diabetes,_and_Cardiovascular_Disease L2 - https://linkinghub.elsevier.com/retrieve/pii/S1934-5909(20)30279-4 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.